reglab/housing_qa huggingface dataset:
MD. Health - General Code Ann. §  13-503 (2021)
2021 Maryland Statutes|Health - General|Title 13 - Miscellaneous Health Care Programs|Subtitle 5 - Arthritis Prevention and Control Act|Section 13-503 - Findings

    The General Assembly finds that:         (1)    Arthritis encompasses more than 100 diseases and conditions that affect joints, the surrounding tissues, and other connective tissues;        (2)    As one of the most common family of diseases in the United States, arthritis affects nearly one of every six Americans and will impact an estimated 60,000,000 people by the year 2020;        (3)    Arthritis is the leading cause of disability in the United States, limiting daily activities for more than 7,000,000 people;        (4)    Although prevailing myths inaccurately portray arthritis as an old person’s disease, arthritis is a multigenerational disease that has become one of the country’s most pressing health problems;        (5)    Arthritis has a significant impact on quality of life for the individual experiencing the painful symptoms and for the family members and caregivers providing for that individual;        (6)    The economic and social costs associated with treating arthritis and the complications of arthritis are estimated at almost $80,000,000,000 annually;        (7)    Currently, the challenge exists to ensure delivery of effective, but often underutilized, interventions that are necessary in the prevention or reduction of arthritis-related pain and disability;        (8)    The large quantity of public information and programs about arthritis remain inadequately disseminated and are insufficient in addressing the needs of specific diverse populations and other underserved groups;        (9)    The Arthritis Foundation, the Centers for Disease Control and Prevention, and the Association of State and Territorial Health Officials have led the development of a public health strategy, the National Arthritis Action Plan, to ensure the delivery of effective, but often underutilized interventions that are necessary in the prevention or reduction of arthritis-related pain and disability; and        (10)    Educating the public and health care community throughout the State about arthritis is of paramount importance and is in every respect in the public interest and to the benefit of all residents of the State.
MD. Health - General Code Ann. §  13-504 (2021)
2021 Maryland Statutes|Health - General|Title 13 - Miscellaneous Health Care Programs|Subtitle 5 - Arthritis Prevention and Control Act|Section 13-504 - Purpose of Subtitle

    The purposes of this subtitle are to:         (1)    Create and foster a statewide program that promotes public awareness and increases knowledge about the causes of arthritis, the importance of early diagnosis and appropriate management, effective prevention strategies, and pain prevention and management;        (2)    Enhance understanding of arthritis by disseminating to patients, health professionals, and the public:            (i)    Educational materials;            (ii)    Information on research results;            (iii)    Information on services provided; and            (iv)    Strategies for prevention and control;        (3)    Establish a solid scientific base of knowledge on the prevention of arthritis and related disability through surveillance, epidemiology, and prevention research;        (4)    Utilize educational and training resources and services developed by organizations with appropriate expertise and knowledge of arthritis and use available technical assistance;        (5)    Evaluate the need for improving the quality and accessibility of existing community-based arthritis services;        (6)    Increase awareness about the prevention, detection, and treatment of arthritis among State and local health officials, providers, professionals, and policy makers;        (7)    Implement and coordinate State and local programs and services to reduce the public health burden of arthritis; and        (8)    Improve the quality of life and contain health care costs for individuals with arthritis and their families.
MD. Health - General Code Ann. §  13-505 (2021)
2021 Maryland Statutes|Health - General|Title 13 - Miscellaneous Health Care Programs|Subtitle 5 - Arthritis Prevention and Control Act|Section 13-505 - Duties of Secretary

    The Secretary shall:        (1)    Provide sufficient staff to implement the Program;        (2)    Provide appropriate training for staff of the Program;        (3)    Identify the appropriate organizations to carry out the Program;        (4)    Base the Program on the most current scientific information and findings;        (5)    Work to increase and improve community–based services available to people with arthritis and their family members;        (6)    Work with governmental offices, national voluntary health organizations and their local chapters, community and business leaders, community organizations, and health care and human service providers to coordinate efforts and maximize State resources in the areas of prevention, education, detection, pain management, and treatment of arthritis; and        (7)    Identify and, when appropriate, use evidence–based arthritis programs and obtain related materials and services from organizations with appropriate expertise and knowledge of arthritis.
MD. Health - General Code Ann. §  13-506 (2021)
2021 Maryland Statutes|Health - General|Title 13 - Miscellaneous Health Care Programs|Subtitle 5 - Arthritis Prevention and Control Act|Section 13-506 - Funding

    The operation, management, and administration of the Program shall be funded as provided for in the State budget.
MD. Health - General Code Ann. §  13-507 (2021)
2021 Maryland Statutes|Health - General|Title 13 - Miscellaneous Health Care Programs|Subtitle 5 - Arthritis Prevention and Control Act|Section 13-507 - Short Title

    This subtitle may be cited as the “Maryland Arthritis Prevention and Control Act”.
MD. Health - General Code Ann. §  13-601 (2021)
2021 Maryland Statutes|Health - General|Title 13 - Miscellaneous Health Care Programs|Subtitle 6 - Early Hearing Detection and Intervention Program|Section 13-601 - Definitions

    (a)    In this subtitle the following words have the meanings indicated.    (b)    “Hearing status” means the state of an individual’s ability to perceive sound, based on audiological assessment.    (c)    “Infant” means a child who is under the age of 1 year.    (d)    “Newborn” means a child up to 29 days old who is born in the State.    (e)    “Program” means the program that the Secretary establishes to provide for universal hearing screening of newborns and early identification and follow–up of newborns and infants who have, or are at risk for developing, a permanent hearing status that affects speech–language skills.
MD. Health - General Code Ann. §  13-602 (2021)
2021 Maryland Statutes|Health - General|Title 13 - Miscellaneous Health Care Programs|Subtitle 6 - Early Hearing Detection and Intervention Program|Section 13-602 - Establishment of Program

    (a)    The Secretary shall establish a program for the universal hearing screening of newborns and early identification and follow–up of newborns and infants who have, or who are at risk for developing, a permanent hearing status that affects speech–language skills.    (b)    The program shall be based on the model system developed by the Department.
MD. Health - General Code Ann. §  13-604 (2021)
2021 Maryland Statutes|Health - General|Title 13 - Miscellaneous Health Care Programs|Subtitle 6 - Early Hearing Detection and Intervention Program|Section 13-604 - Powers and Duties of Secretary

    (a)    The Secretary may contract with any qualified person to administer the Program.    (b)    The Secretary shall:        (1)    Develop a system to gather and maintain data;        (2)    Develop methods to:            (i)    Contact parents or guardians of newborns and their identified primary care providers regarding the results of the newborn hearing screening;            (ii)    Contact parents or guardians of newborns and infants who have, or are at risk for developing, a permanent hearing status that affects speech–language skills; and            (iii)    Ensure families are referred to appropriate services;        (3)    Establish a toll–free telephone line to communicate information about hearing status that affects speech–language skills and services for infants who have, or are at risk for developing, a permanent hearing status that affects speech–language skills;        (4)    Appoint an Advisory Council for the Program;        (5)    Meet annually with the Advisory Council; and        (6)    In consultation with the Advisory Council, adopt rules and regulations necessary to implement the Program.
MD. Health - General Code Ann. §  13-605 (2021)
2021 Maryland Statutes|Health - General|Title 13 - Miscellaneous Health Care Programs|Subtitle 6 - Early Hearing Detection and Intervention Program|Section 13-605 - Results of Hearing Screening of Newborns to Be Included in Birth Event Information

    (a)    As part of the supplemental information required to be submitted to the Department as part of the birth event, a hospital shall include the results of the hearing screening of the newborn.    (b)    The Department may adopt regulations for results reporting procedures for hospitals, birthing sites, and audiologists.
MD. Health - General Code Ann. §  13-701 (2021)
2021 Maryland Statutes|Health - General|Title 13 - Miscellaneous Health Care Programs|Subtitle 7 - Emergency and Allergy Treatment Program|Section 13-701 - Purpose

    The Emergency and Allergy Treatment Program is a program in the Department for the purpose of providing a means of authorizing certain individuals to administer life–saving treatment to individuals who have severe adverse reactions to allergens or insect stings when physician services or emergency medical services are not immediately available in a youth camp.
MD. Health - General Code Ann. §  13-702 (2021)
2021 Maryland Statutes|Health - General|Title 13 - Miscellaneous Health Care Programs|Subtitle 7 - Emergency and Allergy Treatment Program|Section 13-702 - Definitions

    (a)    In this subtitle the following words have the meanings indicated.    (b)    “Agent” means an individual who:        (1)    Is at least 18 years of age;        (2)    Has successfully completed, at the expense of an applicant, an educational training program approved by the Department; and        (3)    Is appointed by a certificate holder to administer auto–injectable epinephrine in accordance with the provisions of this subtitle.    (c)    “Anaphylaxis” means a sudden, severe, and potentially life–threatening allergic reaction that occurs when an individual is exposed to an allergen.    (d)    “Auto–injectable epinephrine” means a portable, disposable drug delivery device that contains a premeasured single dose of epinephrine that is used to treat anaphylaxis in an emergency situation.    (e)    “Certificate” means a certificate or an endorsement on the operating certificate of a youth camp issued by the Department to an individual who operates a youth camp under Title 14, Subtitle 4 of this article to obtain, store, and administer auto–injectable epinephrine.    (f)    “Certificate holder” means an individual who is authorized by the Department to obtain, store, and administer auto–injectable epinephrine to be used in an emergency situation.    (g)    “Program” means the Emergency and Allergy Treatment Program.    (h)    “Youth camp” has the meaning stated in § 14–401 of this article.
MD. Health - General Code Ann. §  13-703 (2021)
2021 Maryland Statutes|Health - General|Title 13 - Miscellaneous Health Care Programs|Subtitle 7 - Emergency and Allergy Treatment Program|Section 13-703 - Authority of Department

    (a)    The Department may:        (1)    Adopt regulations for the administration of the Program;        (2)    Collect fees necessary for the administration of the Program;        (3)    Issue and renew a certificate to a person meeting the requirements of this subtitle; and        (4)    Approve educational training programs, including programs conducted by other State agencies or private entities.    (b)    A certificate issued by the Department shall be valid for up to 1 year.
MD. Health - General Code Ann. §  13-704 (2021)
2021 Maryland Statutes|Health - General|Title 13 - Miscellaneous Health Care Programs|Subtitle 7 - Emergency and Allergy Treatment Program|Section 13-704 - Qualifications

    (a)    To qualify for a certificate, an individual shall meet the requirements of this section.    (b)    The applicant shall operate a youth camp.    (c)    The applicant shall be at least 18 years old.    (d)    The applicant shall successfully complete, at the expense of the applicant, an educational training program approved by the Department.    (e)    An applicant shall have a written policy that includes:        (1)    Authorization for the certificate holder or agent to administer auto–injectable epinephrine, if available, to an individual who has been determined to be or is believed to be experiencing anaphylaxis, whether or not the individual:            (i)    Has previously been known to have experienced anaphylaxis; or            (ii)    Has a prescription for epinephrine prescribed by an authorized health care practitioner licensed under the Health Occupations Article;        (2)    A requirement that youth camp personnel complete training on how to recognize the symptoms of anaphylaxis;        (3)    Procedures for the emergency administration of auto–injectable epinephrine;        (4)    Procedures for proper emergency follow–up;        (5)    Authorization for a certificate holder to obtain and store auto–injectable epinephrine to be used in an emergency; and        (6)    A requirement that each certificate holder implement a method for notifying the parent or guardian of a camper of the youth camp’s policy under this section before the camper’s attendance.
MD. Health - General Code Ann. §  13-705 (2021)
2021 Maryland Statutes|Health - General|Title 13 - Miscellaneous Health Care Programs|Subtitle 7 - Emergency and Allergy Treatment Program|Section 13-705 - Prescribing Auto-Injectable Epinephrine

    (a)    (1)    A physician licensed to practice medicine in the State may prescribe auto–injectable epinephrine in the name of a certificate holder.        (2)    A pharmacist licensed to practice pharmacy in the State or a physician may dispense auto–injectable epinephrine under a prescription issued to a certificate holder.    (b)    A certificate holder may:        (1)    On presentment of a certificate, receive from any physician licensed to practice medicine in the State a prescription for auto–injectable epinephrine and the necessary paraphernalia for the administration of auto–injectable epinephrine; and        (2)    Possess and store prescribed auto–injectable epinephrine and the necessary paraphernalia for the administration of auto–injectable epinephrine.    (c)    In an emergency situation when physician or emergency medical services are not immediately available, a certificate holder or agent may administer auto–injectable epinephrine to an individual who is experiencing or believed in good faith by the certificate holder or agent to be experiencing anaphylaxis.
MD. Health - General Code Ann. §  13-706 (2021)
2021 Maryland Statutes|Health - General|Title 13 - Miscellaneous Health Care Programs|Subtitle 7 - Emergency and Allergy Treatment Program|Section 13-706 - Reports

    (a)    A certificate holder shall submit to the Department, on a form required by the Department, a report of each incident that occurs while the youth camp is in session that required the administration of auto–injectable epinephrine.    (b)    On or before January 31 of each year, the Department shall publish a report summarizing the information obtained from the reports submitted to the Department under subsection (a) of this section.
MD. Health - General Code Ann. §  13-707 (2021)
2021 Maryland Statutes|Health - General|Title 13 - Miscellaneous Health Care Programs|Subtitle 7 - Emergency and Allergy Treatment Program|Section 13-707 - Immunity From Liability -- Certified Individuals or Agents

    (a)    A cause of action may not arise against a certificate holder or agent authorized under this subtitle for any act or omission when the certificate holder or agent is acting in good faith while administering auto–injectable epinephrine to an individual experiencing or believed by the certificate holder or agent to be experiencing anaphylaxis, except where the conduct of the certificate holder or agent amounts to gross negligence, willful or wanton misconduct, or intentionally tortious conduct.    (b)    (1)    A cause of action may not arise against any physician for any act or omission when the physician in good faith prescribes or dispenses auto–injectable epinephrine and the necessary paraphernalia for the administration of auto–injectable epinephrine to a person certified by the Department under this subtitle.        (2)    A cause of action may not arise against any pharmacist for any act or omission when the pharmacist in good faith dispenses auto–injectable epinephrine and the necessary paraphernalia for the administration of auto–injectable epinephrine to a person certified by the Department under this subtitle.    (c)    This section does not affect, and may not be construed as affecting, any immunities from civil liability or defenses established by any other provision of the Code or by common law to which a volunteer, physician, or pharmacist may be entitled.
MD. Health - General Code Ann. §  13-708 (2021)
2021 Maryland Statutes|Health - General|Title 13 - Miscellaneous Health Care Programs|Subtitle 7 - Emergency and Allergy Treatment Program|Section 13-708 - Immunity From Liability -- Uncertified Individuals

    (a)    This subtitle may not be construed to create a duty upon any individual to obtain a certificate under this subtitle, and an individual may not be held civilly liable for failing to obtain a certificate under this subtitle.    (b)    An individual may not be held civilly liable in any action arising from or in connection with the administration of auto–injectable epinephrine by the individual solely because the individual did not possess a certificate issued under this subtitle.
MD. Health - General Code Ann. §  13-7A-01 (2021)
2021 Maryland Statutes|Health - General|Title 13 - Miscellaneous Health Care Programs|Subtitle 7A - Emergency Use Auto-Injectable Epinephrine Program|Section 13-7A-01 - Definitions

    (a)    In this subtitle the following words have the meanings indicated.    (b)    “Agent” means an individual who:        (1)    Is at least 18 years of age;        (2)    Has successfully completed, at the expense of the participating facility, an educational training program approved by the Department under § 13–7A–03 of this subtitle; and        (3)    Is designated by a certificate holder to administer auto–injectable epinephrine in accordance with the provisions of this subtitle.    (c)    “Anaphylaxis” means a sudden, severe, and potentially life–threatening allergic reaction that occurs when an individual is exposed to an allergen.    (d)    “Auto–injectable epinephrine” means a portable, disposable drug delivery device that contains a premeasured single dose of epinephrine that is used to treat anaphylaxis in an emergency situation.    (e)    “Certificate” means a certificate issued by the Department to an individual to obtain, store, and administer auto–injectable epinephrine.    (f)    “Certificate holder” means an individual who is authorized by the Department to obtain, store, and administer auto–injectable epinephrine to be used in an emergency situation.    (g)    “Eligible institution” means an institution of higher education that has a food service facility or a recreation and wellness facility on the premises and that is authorized under this subtitle to obtain and store auto–injectable epinephrine.    (h)    “Food service facility” has the meaning indicated in § 21–301 of this article.    (i)    “Participating facility” means a recreation or wellness facility at an eligible institution or a food service facility, including a food service facility at an eligible institution, in the State that voluntarily participates in the Program.    (j)    “Program” means the Emergency Use Auto–Injectable Epinephrine Program established under § 13–7A–02 of this subtitle.
MD. Health - General Code Ann. §  13-7A-02 (2021)
2021 Maryland Statutes|Health - General|Title 13 - Miscellaneous Health Care Programs|Subtitle 7A - Emergency Use Auto-Injectable Epinephrine Program|Section 13-7A-02 - Emergency Use Auto-Injectable Epinephrine Program

    (a)    There is an Emergency Use Auto–Injectable Epinephrine Program.    (b)    The purpose of the Program is to authorize individuals employed by a participating facility to obtain and store auto–injectable epinephrine and administer auto–injectable epinephrine to individuals who are experiencing or are believed to be experiencing anaphylaxis when a physician or emergency medical services are not immediately available.    (c)    (1)    Subject to paragraph (4) of this subsection, each participating facility may obtain:            (i)    A prescription for a supply of auto–injectable epinephrine from a licensed physician as provided in § 13–7A–06 of this subtitle; and            (ii)    A supply of auto–injectable epinephrine from a licensed pharmacist or a licensed physician as provided in § 13–7A–06 of this subtitle.        (2)    Each participating facility shall store a supply of auto–injectable epinephrine obtained under paragraph (1)(ii) of this subsection:            (i)    In accordance with the manufacturer’s instructions; and            (ii)    In a location that is readily accessible to employees or affiliated individuals in an emergency situation.        (3)    Each participating facility shall designate the employees who are certificate holders or designated affiliated individuals who are certificate holders who will be responsible for the storage, maintenance, and control of the supply of auto–injectable epinephrine.        (4)    A participating facility may not obtain or store auto–injectable epinephrine unless the participating facility has at least two employees or designated affiliated individuals who are certificate holders.        (5)    Each participating facility shall maintain a copy of the certificate issued to an employee or a designated affiliated individual under § 13–7A–05 of this subtitle.
MD. Health - General Code Ann. §  13-7A-03 (2021)
2021 Maryland Statutes|Health - General|Title 13 - Miscellaneous Health Care Programs|Subtitle 7A - Emergency Use Auto-Injectable Epinephrine Program|Section 13-7A-03 - Duties

    (a)    The Department shall:        (1)    Adopt regulations for the administration of the Program;        (2)    Collect fees necessary for the administration of the Program;        (3)    Issue a certificate to, or renew the certificate of, an individual meeting the requirements of § 13–7A–04 of this subtitle;        (4)    Approve educational training programs, including programs conducted by other State agencies or private entities;        (5)    Develop a method by which certificate holders may submit a report to the Department about each incident that occurred on the premises of a participating facility that involved the administration of auto–injectable epinephrine by a certificate holder or an agent; and        (6)    On or before January 31 each year, publish a report summarizing the information obtained from reports submitted to the Department under item (5) of this subsection.    (b)    The Department may:        (1)    Set an application fee for a certificate;        (2)    Establish a fee for the renewal or replacement of a certificate; and        (3)    Require applicants to apply to the Program in the manner the Department chooses.    (c)    An educational training program approved by the Department under subsection (a)(4) of this section may be an online training program.